174 related articles for article (PubMed ID: 31371354)
1. Manganese-Enhanced MRI of the Brain in Healthy Volunteers.
Sudarshana DM; Nair G; Dwyer JT; Dewey B; Steele SU; Suto DJ; Wu T; Berkowitz BA; Koretsky AP; Cortese ICM; Reich DS
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1309-1316. PubMed ID: 31371354
[TBL] [Abstract][Full Text] [Related]
2. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
Wang C; Gordon PB; Hustvedt SO; Grant D; Sterud AT; Martinsen I; Ahlström H; Hemmingsson A
Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962
[TBL] [Abstract][Full Text] [Related]
3. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
4. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks].
Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C
J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779
[TBL] [Abstract][Full Text] [Related]
5. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
[TBL] [Abstract][Full Text] [Related]
6. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
[TBL] [Abstract][Full Text] [Related]
7. Manganese-Enhanced MRI in Patients with Multiple Sclerosis.
Suto DJ; Nair G; Sudarshana DM; Steele SU; Dwyer J; Beck ES; Ohayon J; McFarland H; Koretsky AP; Cortese ICM; Reich DS
AJNR Am J Neuroradiol; 2020 Sep; 41(9):1569-1576. PubMed ID: 32763897
[TBL] [Abstract][Full Text] [Related]
8. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
Yeh BM; Breiman RS; Taouli B; Qayyum A; Roberts JP; Coakley FV
Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
[TBL] [Abstract][Full Text] [Related]
9. Toward clinical application of manganese-enhanced MRI of retinal function.
Tofts PS; Porchia A; Jin Y; Roberts R; Berkowitz BA
Brain Res Bull; 2010 Feb; 81(2-3):333-8. PubMed ID: 19524028
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the stomach: potential use for mangafodipir trisodium--a study in swine.
Zuo CS; Seoane PR; Hu J; Harnish PP; Rofsky NM
Radiology; 2004 Jul; 232(1):160-3. PubMed ID: 15166322
[TBL] [Abstract][Full Text] [Related]
11. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
12. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Mathieu D; Coffin C; Kobeiter H; Caseiro-Alves F; Mahfouz A; Rahmouni A; Diche T
J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
Mayo-Smith WW; Schima W; Saini S; Slater GJ; McFarland EG
AJR Am J Roentgenol; 1998 Mar; 170(3):649-52. PubMed ID: 9490946
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
[TBL] [Abstract][Full Text] [Related]
15. [New possibilities to study biliary tree and gallbladder: functional magnetic resonance cholangiography contrast-enhanced with mangafodipir trisodium (Mn DPDP)].
Laurent V; Corby S; Barbary C; Kermarrec E; Béot S; Régent D
J Radiol; 2007 Apr; 88(4):531-40. PubMed ID: 17464251
[TBL] [Abstract][Full Text] [Related]
16. Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI.
Wang C; Johansson L; Western A; Fagertun H; Ahlström H
J Magn Reson Imaging; 1999 Feb; 9(2):280-4. PubMed ID: 10077025
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and pharmacokinetics of MnDPDP in man.
Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T
Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963
[TBL] [Abstract][Full Text] [Related]
18. NMR relaxation studies with MnDPDP.
Southon TE; Grant D; Bjørnerud A; Moen OM; Spilling B; Martinsen I; Refsum H
Acta Radiol; 1997 Jul; 38(4 Pt 2):708-16. PubMed ID: 9245966
[TBL] [Abstract][Full Text] [Related]
19. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
